IAS 2025 conference hall in Kigali, Rwanda (Credit: Kyle LaHucik for Endpoints News)
July 16, 2025 05:56 AM EDTUpdated 07:21 AM
In Focus

As PEP­FAR fund­ing gets a life­line, HIV lead­ers warn of re­gres­sion for the field

Kyle LaHucik

Biotech Correspondent

KI­GALI, RWAN­DA — The open­ing night mes­sage was clear.

“UN­AIDS warns that if ur­gent steps are not tak­en, we may find our­selves back in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PureTech CEO leaves just one week af­ter long­time chair steps down

As­traZeneca says amy­loi­do­sis drug fails Phase 3 tri­als, but claims po­ten­tial in undis­closed sub­group

Prime Med­i­cine CSO de­parts, re­veals new fund­ing; FDA lifts par­tial hold on Kezar drug

De­bio­pharm li­cens­es Re­pare’s first-in-class can­cer drug for $10M up­front

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

Up­dat­ed: J&J's Ste­lara faces con­tin­ued biosim­i­lar com­pe­ti­tion, with Q2 rev­enue falling 43%

A service from the Financial Times